UK Guidelines For Prescribing Support System

6 January 1997

In February 1996, the UK Department of Health asked the Association ofthe British Pharmaceutical Industry, as part of the National Health Service's PRODIGY (Prescribing Rationally with Decision Support in General Practice) initiative, to give its views on how national guidelines for prescribing support systems in primary care should be developed. To this end, the ABPI commissioned a report from the Deloitte & Touche Consulting group.

This report concluded that an independent body should be established to ensure the development and use of high-quality clinical guidelines (as reported briefly in Marketletter December 9).

It also made clear that there exists a need both for further research on clinical guidelines and their impact on the quality of care in the UK, and for funding some form of recognized body with expertise in the field of guideline development, review and implementation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight